Integer Holdings Corp

Integer Holdings Corp(ITGR)の株式分析

$125.330

+0.025 (+0.02%)終値時点

Loading chart…
High
125.450
Open
125.450
VWAP
125.34
Vol
569.65K
Mkt Cap
3.84B
Low
125.230
Amount
71.40M
EV/EBITDA, TTM
16.90

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.

AI analysis of Integer Holdings Corp (ITGR)

hold

Integer Holdings Corp is not a good buy right now. The current price is $125.33, which is very close to the acquisition price of $127 set by KKR, limiting upside potential. Additionally, the RSI is at 75.998, indicating that the stock is overbought. While the company reported a Q2 non-GAAP EPS of $1.60, beating expectations, the withdrawal of future guidance due to the acquisition raises concerns about future performance. The main risk is the uncertainty surrounding the acquisition and potential fiduciary breaches, as highlighted by recent investigations.

Analyst Ratings (5)

-31.18% downside
Hold
2 Buy
3 Hold
0 Sell
Current: 125.33
安値
75.00
平均
86.25
高値
95.00

Benchmark

2026-08-13

目標株価

Hold

Piper Sandler

2026-08-03

目標株価

$127

Neutral

KeyBanc

2026-08-03

目標株価

$127

Sector Weight

BofA

2026-08-03

目標株価

No Rating

Freedom Capital

2026-07-22

目標株価

$112

Buy

バリュエーション指標

The current forward P/E ratio for Integer Holdings Corp (ITGR) is 26.39, compared to its 5-year average forward P/E of 18.69.

Forward P/E

Strongly Overvalued
5Y Average P/E
18.69
Current P/E
26.39
割高
21.78
割安
15.60

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
12.78
Current EV/EBITDA
16.90
割高
14.32
割安
11.24

Forward P/S

Fair
5Y Average P/S
1.90
Current P/S
2.21
割高
2.25
割安
1.56

Alphio AI Price Scenarios for ITGR

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ITGR

$140.04

シナリオ価格

B

Base

Base · 50%ITGR

$133.90

シナリオ価格

B

Bear

Bear · 25%ITGR

$130.08

シナリオ価格

Whales holding ITGR

H

Heartland Advisors, Inc.

+ HoldingITGR

+5.63%

3M Return

H

Hudson Bay Capital Management LP

+ HoldingITGR

-5.46%

3M Return

イベントタイムライン

2026-08-04 (ET)

06:30:00

Freedom Capital Downgrades Integer to Hold, Price Target $127

2026-08-03 (ET)

17:00:00

U.S. Stocks Rise as Middle East Tensions Ease, Oil Prices Drop 5%

17:00:00

Oppenheimer Downgrades Integer to Perform

12:00:00

Amazon's Market Cap Surpasses $3 Trillion

11:30:00

Truist Downgrades Integer to Hold with $127 Price Target

ニュース

ITGR FAQ — answered by Alphio AI

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Integer Holdings Corp is not a good buy right now. The current price is $125.33, which is very close to the acquisition price of $127 set by KKR, limiting upside potential. Additionally, the RSI is at 75.998, indicating that the stock is overbought. While the company reported a Q2 non-GAAP EPS of $1.60, beating expectations, the withdrawal of future guidance due to the acquisition raises concerns about future performance. The main risk is the uncertainty surrounding the acquisition and potential fiduciary breaches, as highlighted by recent investigations.

5 analysts cover ITGR: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 86.25.

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

無料で始める